Adding Menin Inhibitor Promising in Certain AML Patients

(MedPage Today) — Adding the menin inhibitor revumenib (Revuforj) to azacitidine and venetoclax (Venclexta) seemed to benefit older adults with newly diagnosed NPM1-mutated or KMT2A-rearranged acute myeloid leukemia (AML), according to results…

Source link : https://www.medpagetoday.com/meetingcoverage/eha/116071

Author :

Publish date : 2025-06-13 18:01:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
				1	2	3
4	5	6	7	8	9	10
11	12	13	14	15	16	17
18	19	20	21	22	23	24
25	26	27	28	29	30	31

Adding Menin Inhibitor Promising in Certain AML Patients

Perseverance rover may hold secrets to newly discovered Mars volcano

Early Smartphone-Activated Bystander CPR Can Boost Survival

Related Posts

Excessive Daytime Sleepiness Linked to Diet and Hormones

What’s Up With Trump’s Hand Bruise? Doctors Have Theories

Detecting and Intervening Against Elder Abuse: Tips

Deeper Cuts at HHS; Food Safety Rollbacks; Old Paxil Study Scrutinized

Glow-in-the-dark plants to replace streetlights? Forget it

Patients struggle to get weight loss drug ahead of price rise

Excessive Daytime Sleepiness Linked to Diet and Hormones

What’s Up With Trump’s Hand Bruise? Doctors Have Theories

Detecting and Intervening Against Elder Abuse: Tips

Deeper Cuts at HHS; Food Safety Rollbacks; Old Paxil Study Scrutinized

Glow-in-the-dark plants to replace streetlights? Forget it

Patients struggle to get weight loss drug ahead of price rise

Global Prevalence of Hidradenitis Suppurativa Near 1%

Policy Lag on HIV, Breastfeeding Persists in Latin America

Categories

Archives